Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Alexion Pharm Inc (ALXN)

112.96 -0.32 (-0.28%)

04-18 16:00

Open:

113.61

Pre. Close:

113.28

High:

113.7

Low:

112.28

Volume:

1,130,068

Market Cap:

25118M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

113.867 - 114.441

114.441 - 114.913

Low:

110.944 - 111.556

111.556 - 112.059

Close:

112.064 - 113.023

113.023 - 113.811

Technical analysis  (as of: 2018-04-18 4:38:02 PM)

Overall:

      

Stoxline posted a BUY today, same as yesterday. This stock seems to continue bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, upward move is expected.

Target:

Six months: 146.86     One year: 161.04

Support:

Support1: 106.10    Support2: 88.28

Resistance:

Resistance1: 125.74    Resistance2: 137.88

Pivot:

110.77

Moving Averages:

MA(5): 111.68     MA(20): 111.22

MA(100): 116.74     MA(250): 123.06

MACD:

MACD(12,26): -1.50     Signal(12,26,9): -1.99

%K %D:

%K(14,3): 69.59     %D(3): 60.72

RSI:

RSI(14): 49.18

52-Week:

High: 149.34  Low: 96.18  Change(%): -4.9

Average Vol(K):

3-Month: 214268  10-Days 163078

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
ALXN has closed below upper band by 17.1%. Bollinger Bands are 50.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to ALXN's normal range. The bands have been in this narrow range for 4 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

2018-04-17T11:46:21-04:00
JF's Core Biotech Buys #11: Positive News For Several Holdings, A Change To Benchmarks And Introducing Our 17th Position

2018-04-16T12:05:10-04:00
Biotech Forum: The Week Ahead

2018-04-13T01:45:09-04:00
Alexion Spruces Up Its Pipeline With $855 Million Buy Of Rare Disease Drug Maker

2018-04-12T13:50:23-04:00
Alexion Pharmaceuticals (ALXN) To Acquire Wilson Therapeutics - Slideshow

2018-04-12T10:00:00-04:00
Alexion to Report First Quarter 2018 Results on Thursday, April 26, 2018

2018-04-12T02:50:41-04:00
Alexion Joins The Biotech M&A Bonanza

2018-04-12T02:01:03-04:00
Omeros Corporation: What The Recent Credit Facility Amendment Foretells

2018-04-11T06:45:39-04:00
Alexion to acquire Wilson Therapeutics for $855M

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biopharmaceuticals

Shares Out. (M)

222.36

Shares Float (M)

220.02

% Held by Insiders

1.10

% Held by Institutions

Shares Short (K)

4497

Shares Short Prior Month (K)

5230

Stock Financials

EPS

5.070

EPS Est. Current Year

5.620

EPS Est. Next Year

7.130

EPS Est. Next Quarter

1.570

Forward EPS

8.457

Book Value (p.s.)

2.780

PEG Ratio

0.96

Profit Margin

10.19

Operating Margin

27.69

Return on Assets (ttm)

3.3

Return on Equity (ttm)

5.0

Qtrly Rev. Growth

9.5

Gross Profit (p.s.)

13.928

Sales Per Share

EBITDA (p.s.)

5.140

Qtrly Earnings Growth

-67.60

Operating Cash Flow (M)

1120.00

Levered Free Cash Flow (M)

879.16

atoplab.com

Valuation

P/E

22.28

P/E Growth Ratio

P/BV

40.63

P/S

1583719168.00

P/CF

22.43

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

2011-05-23

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.